Grasshopper mice use a venom peptide to block pain outside the brain. Rowe's lab is reworking it with AlphaFold, and OU has filed a patent application.
Recap by typeshit. Full story at The University of Oklahoma.
Among 208,970 matched adults with type 2 diabetes, GLP-1 starters had 0.15% new diagnoses versus 0.10% on DPP-4 drugs. Authors call it a signal needing confirmation.
Researchers used AI to identify fungal peptides that taste salty or boost saltiness, aimed at cutting sodium in food. A food science find rather than a drug story.
The 1,200-person trial starts next year with MIT and Pitt researchers, funded by a $13 million Arnold Ventures grant, and will also track housing and jobs.
Researchers found the peptide they built as a treatment already circulates in human blood, at lower levels in people with cognitive impairment.
Reuters reports the agency submitted the proposal for review on October 15, a step that could affect compounded peptides such as BPC-157.
In 485 insulin-naive type 2 diabetes patients, icodec plus semaglutide cut HbA1c more and trimmed weight while glargine users gained 3.81 kg, though GI side effects ran higher.
Loading…